Company news

Accendra Health, Inc. news in 2026

Accendra Health, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Accendra Health Reports Third Quarter 2026 Financial Results

November 5, 2026

Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029

November 2, 2026

Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard​

October 30, 2026

Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call

October 22, 2026

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

October 9, 2026

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

September 17, 2026

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

August 17, 2026

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

August 11, 2026

Accendra Health Reports Second Quarter 2026 Financial Results

August 10, 2026

Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

August 10, 2026

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

July 27, 2026

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

June 23, 2026

Accendra Health Announces Early Results of Offers and Consent Solicitations

June 10, 2026

Accendra Health Announces Offers and Consent Solicitations

May 22, 2026

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

May 11, 2026

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

May 1, 2026

Owens & Minor Appoints Chief Products Officer

March 30, 2026

Accendra Health Reports Fourth Quarter 2025 Financial Results Prepared Remarks

February 20, 2026

Accendra Health Reports Fourth Quarter 2025 Financial Results

February 19, 2026

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

February 5, 2026

Owens & Minor Names New Chief Commercial Officer

February 4, 2026

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

January 2, 2026

Calls in 2026

Decks in 2026